Advertisement

Revance Therapeutics Company Profile

08:12 EDT 21st May 2013 | BioPortfolio

Revance Therapeutics is a specialty pharmaceutical company formed to discover, develop and commercialize therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. The Company’s core clinical targets are in areas of aesthetic medicine and therapeutic dermatology.

Location

2400 Bayshore Parkway, Suite 100
Mountain View
California
94043
United States of America

Contact

Phone: 650-230-4500
Fax: 650-230-4501


News Articles [ 10 Associated News Articles listed on BioPortfolio]

Revance Therapeutics raises $33 million in financing

Revance Therapeutics has raised $33 million of its Series E growth financing. In addition, Revance announced the conversion of $71 million in convertible debt into the Series E preferred stock. The pr...

Revance will pay up to $25m to regain botox rights from Medicis

After Revance Therapeutics got to the end of Phase II for RT001 – its botulinum toxin type A gel to reduce crow's feet – the private company sued its partner when the Valeant Pharmaceutica...

Revance raises $33m for topical Botox competitor

After Revance Therapeutics bought out a competitor's option to acquire its needle-free alternative to Allergan's Botox (onabotulinumtoxinA) injections, the company has raised new venture capital so th...

Revance Therapeutics Announces $33 Million Series E Financing

Revance Therapeutics, Inc. (Revance), a privately held specialty biopharmaceutical company developing novel botulinum toxin products for use in aesthetic and therapeutic indicatio...

Revance closes $33 million series E

Revance Therapeutics Inc. (Newark, Calif.) raised $33 million in a series E round led by existing investors NovaQuest Pharma and Essex Woodlands. New investor Delphi Ventures also participated, along...

Revance Therapeutics Announces Appointment of Lauren Silvernail as Chief Financial Officer

Revance Therapeutics, Inc. (Revance) today announced the appointment of Lauren Silvernail as Chief Financial Officer and Executive Vice President of Corporate Development effectiv...

Medicis, Revance deal

Revance management update

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [ 2 Associated Companies listed on BioPortfolio]

Revance Therapeutics, Inc.

Revance Therapeutics, Inc. is a privately-held specialty biopharmaceutical company, which has developed the proprietary TransMTS™ platform technology that enables local, targ...

Revance Therapeutics

Revance Therapeutics is a specialty pharmaceutical company formed to discover, develop and commercialize therapeutic products for treating chronic disease and age-related changes to skin and soft tiss...

More Information about "Revance Therapeutics" on BioPortfolio

We have published hundreds of Revance Therapeutics news stories on BioPortfolio along with dozens of Revance Therapeutics Clinical Trials and PubMed Articles about Revance Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Revance Therapeutics Companies in our database. You can also find out about relevant Revance Therapeutics Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement